197 related articles for article (PubMed ID: 15363539)
1. Genetic progression of metastatic melanoma.
Rodolfo M; Daniotti M; Vallacchi V
Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
[TBL] [Abstract][Full Text] [Related]
2. Novel biomarkers in malignant melanoma.
Bosserhoff AK
Clin Chim Acta; 2006 May; 367(1-2):28-35. PubMed ID: 16480699
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous melanoma susceptibility and progression genes.
de Snoo FA; Hayward NK
Cancer Lett; 2005 Dec; 230(2):153-86. PubMed ID: 16297704
[TBL] [Abstract][Full Text] [Related]
4. Prognostic signs in melanoma: state of the art.
Lomuto M; Calabrese P; Giuliani A
J Eur Acad Dermatol Venereol; 2004 May; 18(3):291-300. PubMed ID: 15096138
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.
Lewis TB; Robison JE; Bastien R; Milash B; Boucher K; Samlowski WE; Leachman SA; Dirk Noyes R; Wittwer CT; Perreard L; Bernard PS
Cancer; 2005 Oct; 104(8):1678-86. PubMed ID: 16116595
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in signaling pathways in melanoma.
Haluska FG; Tsao H; Wu H; Haluska FS; Lazar A; Goel V
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2301s-2307s. PubMed ID: 16609049
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
8. [Genotypic hypervariability of melanoma: a therapeutic challenge].
Dalle S; Martin-Denavit T; Thomas L
Med Sci (Paris); 2006 Feb; 22(2):178-82. PubMed ID: 16457759
[TBL] [Abstract][Full Text] [Related]
9. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
[TBL] [Abstract][Full Text] [Related]
10. Molecular and genetic mechanisms in melanoma.
Gruber F; Kastelan M; Brajac I; Saftić M; Peharda V; Cabrijan L; Stanić Zgombić Z; Simonić E
Coll Antropol; 2008 Oct; 32 Suppl 2():147-52. PubMed ID: 19138018
[TBL] [Abstract][Full Text] [Related]
11. [New insights on genetics of malignant melanoma].
Zigmund M; Nikuseva-Martić T; Cacić M; Pećina-Slaus N
Lijec Vjesn; 2005; 127(3-4):89-93. PubMed ID: 16193861
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract][Full Text] [Related]
14. BRAF kinase in melanoma development and progression.
DeLuca AM; Srinivas A; Alani RM
Expert Rev Mol Med; 2008 Feb; 10():e6. PubMed ID: 18279546
[TBL] [Abstract][Full Text] [Related]
15. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
Zhang H; Sun XF; Synnerstad I; Rosdahl I
Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
Stark M; Hayward N
Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the melanoma interactome.
Reed JA
J Cutan Pathol; 2008 Nov; 35 Suppl 2():11-5. PubMed ID: 18976413
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with melanoma incidence and prognosis.
Lee JE
Semin Surg Oncol; 1996; 12(6):379-85. PubMed ID: 8914201
[TBL] [Abstract][Full Text] [Related]
20. The genetics of skin cancer.
Tsai KY; Tsao H
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):82-92. PubMed ID: 15468170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
